Mayer–Rokitansky–Küster–Hauser (MRKH) syndrome is a congenital condition characterized by agenesis or severe hypoplasia of the uterus and the upper two-thirds of the vagina, with a normal 46,XX karyotype and preserved ovarian function. This author’s protocol integrates international recommendations (ESHRE/ESGE2013, ASRM MAC 2021, ACOG 2018) with two original components: (1) MRKH-MIND, a structured psychological support program adapted for Ukrainian-speaking patients and based on CBT-MRKH with additional ACT and somatic experiencing modules; and (2) MRKH-PELVI, a four-phase pelvic floor therapy program designed to prepare patients for vaginal dilation, reduce pelvic floor hypertonus, improve proprioception, andsupport sexual health. The protocol also introduces RPS-SCORE as a monitoring tool for reproductive pause syndrome. It defines multidisciplinary roles, integration points, timelines, outcomes, and limitations. The protocol is intended for specialized reproductive centers and requires prospective validation.
No takes yet. Share an insight, caveat, or question.
Viktoriya Hudziak (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: